Pediatrix Medical Group, Inc.

For the period ended Dec 31, 2025. Filed Feb 19, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 19, 2026

MD$31.62+0.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets at December 31, 2025 and 2024

Consolidated Balance Sheets

(in thousands, except share data)

	December 31,
	2025	2024
ASSETS
Current assets:
Cash and cash equivalents	$375,241	$229,940
Short-term investments	124,482	118,566
Accounts receivable, net	229,665	259,990
Prepaid expenses	12,606	13,410
Income taxes receivable	12,641	12,614
Other current assets	8,879	5,087
Total current assets	763,514	639,607
Property and equipment, net	39,180	39,172
Goodwill	1,260,732	1,242,606
Intangible assets, net	16,862	11,595
Operating and finance lease right-of-use assets	34,330	39,267
Deferred income tax assets	73,922	103,855
Other assets	58,156	76,598
Total assets	$2,246,696	$2,152,700
LIABILITIES & SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable and accrued expenses	$419,530	$398,690
Current portion of debt and finance lease liabilities, net	26,806	20,545
Current portion of operating lease liabilities	11,591	12,704
Income taxes payable	984	2,171
Total current liabilities	458,911	434,110
Long-term debt and finance lease liabilities, net	570,532	597,119
Long-term operating lease liabilities	25,686	31,945
Long-term professional liabilities	238,353	257,455
Deferred income tax liabilities	57,024	34,246
Other liabilities	30,336	32,887
Total liabilities	1,380,842	1,387,762
Commitments and contingencies
Shareholders’ equity:
Preferred stock; $.01 par value; 1,000,000 shares authorized; none issued	—	—
Common stock; $.01 par value; 200,000,000 shares authorized; 82,976,110 and 85,866,000 shares issued and outstanding, respectively	830	859
Additional paid-in capital	947,566	1,013,690
Accumulated other comprehensive income (loss)	610	(1,071)
Retained deficit	(83,152)	(248,540)
Total shareholders’ equity	865,854	764,938
Total liabilities and shareholders' equity	$2,246,696	$2,152,700

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.